The extracellular matrix: A dynamic niche in cancer progression
Open accessThe DOI matches its Crossref record; 143 of the 144 references it cites were found in a registry or an index.
Abstract
The local microenvironment, or niche, of a cancer cell plays important roles in cancer development. A major component of the niche is the extracellular matrix (ECM), a complex network of macromolecules with distinctive physical, biochemical, and biomechanical properties. Although tightly controlled during embryonic development and organ homeostasis, the ECM is commonly deregulated and becomes disorganized in diseases such as cancer. Abnormal ECM affects cancer progression by directly promoting cellular transformation and metastasis. Importantly, however, ECM anomalies also deregulate behavior of stromal cells, facilitate tumor-associated angiogenesis and inflammation, and thus lead to generation of a tumorigenic microenvironment. Understanding how ECM composition and topography are maintained and how their deregulation influences cancer progression may help develop new therapeutic interventions by targeting the tumor niche.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Besides its biochemical composition, such as intermolecular covalent cross-linkages, the ECM biophysical characteristics include its topography, stiffness/rigidity, molecular density, and tension [118].”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This biochemical framework imparts key biophysical properties to the tumor tissue, including stiffness, porosity, insolubility, and molecular density [5,77,78,79]. These characteristics serve as biomechanical cues that modulate diverse cellular processes, such as migration, proliferation, polarity maintenance, and lineage specification [25,80].”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [79]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“There is an extensive body of experimental data indicating that remodeling of the ECM promotes cancer invasion and metastasis [42, 43].”
From The hypoxic tumor microenvironment: A driving force for breast cancer progression (2016) · cites this paper as [43]
The cited source says what the claim attributes to it.
In the citing paper
“The ECM is known to influence cell behavior in terms of cell migration, and anchorage, by serving as a medium to transmit external forces from environmental cues and even cell signaling throughout the entire lifespan of the cell and at critical phases in their lives [19,20].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“Mechanical properties, e.g., ECM stiffness, of the cell and tissue microenvironment are known to play an important role in cell survival [53,54], proliferation[55], migration[56], and tissue differentiation[57,58].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Self-citationMatrix elasticity directs stem cell lineage specification
Engler, A. J., Sen, S., Sweeney, H. L., & Discher, D. E. (2006) · Cell · doi:10.1016/j.cell.2006.06.044 · Cited by 13,915
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151
Self-citationHuman mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511
The extracellular matrix at a glance
Frantz, C., Stewart, K. M., & Weaver, V. M. (2010) · Journal of Cell Science · doi:10.1242/jcs.023820 · Cited by 4,334
Self-citationCell Shape, Cytoskeletal Tension, and RhoA Regulate Stem Cell Lineage Commitment
McBeath, R., Pirone, D. M., Nelson, C. M., Bhadriraju, K., & Chen, C. S. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00075-9 · Cited by 4,180
Cited by
Items 101–200 of 1,013
The PDGF/PDGFR pathway as a drug target
Papadopoulos, N., & Lennartsson, J. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.11.007 · Cited by 283
Nanomaterials for cancer immunotherapy
Song, W., Musetti, S. N., & Huang, L. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.09.017 · Cited by 281
Wu, Q., Zhou, L., Lv, D., Zhu, X., & Tang, H. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0739-0 · Cited by 281
“Abnormal ECM in the TME can play a critical role in promoting angiogenesis and inflammation [48].”
Tailoring nanoparticle designs to target cancer based on tumor pathophysiology
Sykes, E. A., Dai, Q., Sarsons, C. D., Chen, J., Rocheleau, J. V., Hwang, D. M., Zheng, G., Cramb, D. T., Rinker, K. D., & Chan, W. C. W. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521265113 · Cited by 281
YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer
Noguchi, S., Saito, A., & Nagase, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113674 · Cited by 277
“Indeed, ECM stiffness is correlated with the progression and a poor prognosis of cancer [111,113].”
BackgroundHypoxia-Dependent Modification of Collagen Networks Promotes Sarcoma Metastasis
Eisinger-Mathason, T. S. K., Zhang, M., Qiu, Q., Skuli, N., Nakazawa, M. S., Karakasheva, T., Mucaj, V., Shay, J. E. S., Stangenberg, L., Sadri, N., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0118 · Cited by 277
Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance
Xiong, G., Stewart, R. L., Chen, J., Gao, T., Scott, T. L., Samayoa, L. M., O’Connor, K., Lane, A. N., & Xu, R. (2018) · Nature Communications · doi:10.1038/s41467-018-06893-9 · Cited by 274
Influencing factors and strategies of enhancing nanoparticles into tumors in vivo
Zhang, M., Gao, S., Yang, D., Fang, Y., Lin, X., Jin, X., Liu, Y., Liu, X., Su, K., & Shi, K. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.033 · Cited by 274
Engineering and physical sciences in oncology: challenges and opportunities
Mitchell, M. J., Jain, R. K., & Langer, R. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.83 · Cited by 273
Three-dimensional in vitro culture models in oncology research
Jubelin, C., Muñoz-Garcia, J., Griscom, L., Cochonneau, D., Ollivier, E., Heymann, M.-F., Vallette, F. M., Oliver, L., & Heymann, D. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00887-3 · Cited by 264
Mechanotransduction at the cell-matrix interface
Jansen, K. A., Atherton, P., & Ballestrem, C. (2017) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.07.027 · Cited by 269
Regulation of the anti-tumour immune response by cancer-associated fibroblasts
Harper, J., & Sainson, R. C. A. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.12.005 · Cited by 268
Vennin, C., Chin, V. T., Warren, S. C., Lucas, M. C., Herrmann, D., Magenau, A., Melenec, P., Walters, S. N., del Monte-Nieto, G., Conway, J. R. W., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aai8504 · Cited by 267
“cell proliferation, invasion, andmetastasis (85, 86).”
Strategies to improve tumor penetration of nanomedicines through nanoparticle design
Zhang, Y., Lin, R., Li, H., He, W., Du, J., & Wang, J. (2019) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1519 · Cited by 268
Control of stem cell fate and function by engineering physical microenvironments
Kshitiz, Park, J., Kim, P., Helen, W., Engler, A. J., Levchenko, A., & Kim, D.-H. (2012) · Integrative Biology · doi:10.1039/c2ib20080e · Cited by 267
Møller, H. G., Rasmussen, A. P., Andersen, H. H., Johnsen, K. B., Henriksen, M., & Duroux, M. (2013) · Molecular Neurobiology · doi:10.1007/s12035-012-8349-7 · Cited by 266
“Much of this could be attributed to the experimental framework of the studies, different models, and the well-known fact that the tumor niche is a governing factor with respect to gene regulation and expression [84, 85].”
ResultStromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors
Miao, L., Lin, C. M., & Huang, L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.017 · Cited by 264
Discovering Cell-Adhesion Peptides in Tissue Engineering: Beyond RGD
Huettner, N., Dargaville, T. R., & Forget, A. (2018) · Trends in Biotechnology · doi:10.1016/j.tibtech.2018.01.008 · Cited by 263
Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies
Mhaidly, R., & Mechta-Grigoriou, F. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101417 · Cited by 259
“Increased ECM rigidity resulting from thickening of collagen fibers provides cues favoring migration, attachment, survival and proliferation of cancer cells [229].”
MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent
Zhou, Z., Qutaish, M., Han, Z., Schur, R. M., Liu, Y., Wilson, D. L., & Lu, Z.-R. (2015) · Nature Communications · doi:10.1038/ncomms8984 · Cited by 260
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
Kirtane, A. R., Kalscheuer, S. M., & Panyam, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.001 · Cited by 258
Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy
Yang, S., & Gao, H. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.004 · Cited by 256
Mhaidly, R., & Mechta‐Grigoriou, F. (2021) · Immunological Reviews · doi:10.1111/imr.12978 · Cited by 231
Molecular imaging of the tumor microenvironment
Zhou, Z., & Lu, Z.-R. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.07.012 · Cited by 253
“The tumor ECM is highly deregulated and composed of distinct components, including modified collagens, fibrin, fibronectin, tenascin-C and laminins with different biochemical and physical properties [88].”
BackgroundStock, K., Estrada, M. F., Vidic, S., Gjerde, K., Rudisch, A., Santo, V. E., Barbier, M., Blom, S., Arundkar, S. C., Selvam, I., et al. (2016) · Scientific Reports · doi:10.1038/srep28951 · Cited by 253
Cancer stem cell plasticity and tumor hierarchy
Cabrera, M. C. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i1.27 · Cited by 252
Design of spherically structured 3D in vitro tumor models -Advances and prospects
Ferreira, L. P., Gaspar, V. M., & Mano, J. F. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.05.034 · Cited by 249
Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts
Shi, X., Young, C. D., Zhou, H., & Wang, X.-J. (2020) · Biomolecules · doi:10.3390/biom10121666 · Cited by 243
The Role of Cancer-Associated Fibroblasts in Cancer Invasion and Metastasis
Asif, P. J., Longobardi, C., Hahne, M., & Medema, J. P. (2021) · Cancers · doi:10.3390/cancers13184720 · Cited by 248
“Some of the main contributors of cancerrelated ECM remodeling are deregulated lysyl oxidases (LOXs), matrix metalloproteinases (MMPs), and transglutaminases (TGMs) [2,19,20].”
BackgroundFibroblasts in the Tumor Microenvironment: Shield or Spear?
Alkasalias, T., Moyano-Galceran, L., Arsenian-Henriksson, M., & Lehti, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051532 · Cited by 247
“via processes closely attributed to the over-activation of lysyl oxidase (LOX), an enzyme that crosslinks collagen and other ECM components [130].”
BackgroundFattet, L., Jung, H.-Y., Matsumoto, M. W., Aubol, B. E., Kumar, A., Adams, J. A., Chen, A. C., Sah, R. L., Engler, A. J., Pasquale, E. B., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.05.031 · Cited by 245
“During tumor development, increased deposition, modification and remodeling of the ECM generate a highly fibrotic tumor microenvironment with increased matrix rigidity, which is associated with poor patient prognosis (Wei et al., 2015; Chang et al., 2013; Mujtaba et al., 2013; Lu et al., 2012; Levental et al., 2009; P…”
BackgroundCancer Associated Fibroblasts: The Architects of Stroma Remodeling
Santi, A., Kugeratski, F. G., & Zanivan, S. (2018) · PROTEOMICS · doi:10.1002/pmic.201700167 · Cited by 244
Wullkopf, L., West, A.-K. V., Leijnse, N., Cox, T. R., Madsen, C. D., Oddershede, L. B., & Erler, J. T. (2018) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-05-0319 · Cited by 242
Mammary epithelial cell interactions with fibronectin stimulate epithelial-mesenchymal transition
Park, J., & Schwarzbauer, J. E. (2014) · Oncogene · doi:10.1038/onc.2013.118 · Cited by 240
“Treatment of MCF-10A cells with 5 ng/ml TGF β 1 for 2 days induced dramatic increases in FN, Snail, and N-cadherin mRNAs (63, 35, and 16-fold, respectively) but did not significantly change E-cadherin expression (JP, unpublished observations).”
The extracellular matrix as a key regulator of intracellular signalling networks
Hastings, J. F., Skhinas, J. N., Fey, D., Croucher, D. R., & Cox, T. R. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14195 · Cited by 242
“The extracellular matrix (ECM) makes up the complex network of macromolecules that surrounds cells and tissues and not only provides structural and mechanical support but is also fundamentally important in modulating cellular activity via the activation or suppression of intracellular signalling pathways (Lu et al., 2…”
BackgroundBrown, G. T., & Murray, G. I. (2015) · The Journal of Pathology · doi:10.1002/path.4586 · Cited by 241
“The tumour microenvironment is critical to promoting tumourigenesis and there is currently significant interest in how the mechanical structure of the ECM influences tumour progression [69,70].”
BackgroundDou, C., Liu, Z., Tu, K., Zhang, H., Chen, C., Yaqoob, U., Wang, Y., Wen, J., van Deursen, J., Sicard, D., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.02.015 · Cited by 240
Naba, A., Clauser, K. R., Whittaker, C. A., Carr, S. A., Tanabe, K. K., & Hynes, R. O. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-518 · Cited by 236
Tumor microenvironment components: Allies of cancer progression
Ribeiro Franco, P. I., Rodrigues, A. P., de Menezes, L. B., & Pacheco Miguel, M. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152729 · Cited by 237
Interstitial fluid flow in cancer: implications for disease progression and treatment
Munson, J., & Shieh, A. (2014) · Cancer Management and Research · doi:10.2147/cmar.s65444 · Cited by 235
Tissue Force Programs Cell Fate and Tumor Aggression
Northey, J. J., Przybyla, L., & Weaver, V. M. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0733 · Cited by 237
“These effects of the ECM on cell behavior may manifest gradually and chronically over time; consequently, an aberrant stiffening of tissue due to an overproduction of collagens and proteoglycans, or collagen cross-linking enzymes, can lead to chronic conditions of fibrosis and inflammation with potential ramifications…”
Self-citationLi, C. C., Eaton, S. A., Young, P. E., Lee, M., Shuttleworth, R., Humphreys, D. T., Grau, G. E., Combes, V., Bebawy, M., Gong, J., et al. (2013) · RNA Biology · doi:10.4161/rna.25281 · Cited by 236
Kanapathipillai, M., Brock, A., & Ingber, D. E. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.005 · Cited by 234
The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Kahrilas, P. J., & Boeckxstaens, G. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 235
Microfluidic modelling of the tumor microenvironment for anti-cancer drug development
Shang, M., Soon, R. H., Lim, C. T., Khoo, B. L., & Han, J. (2019) · Lab on a Chip · doi:10.1039/c8lc00970h · Cited by 227
Adipose extracellular matrix remodelling in obesity and insulin resistance
Lin, D., Chun, T.-H., & Kang, L. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.05.005 · Cited by 231
“However, it is shown that these ECM remodelling in cancer are to facilitate tumor cell growth, invasion, and metastasis [9,101].”
InfluentialBarthes, J., Özçelik, H., Hindié, M., Ndreu-Halili, A., Hasan, A., & Vrana, N. E. (2014) · BioMed Research International · doi:10.1155/2014/921905 · Cited by 230
Sequential Intra‐Intercellular Nanoparticle Delivery System for Deep Tumor Penetration
Ju, C., Mo, R., Xue, J., Zhang, L., Zhao, Z., Xue, L., Ping, Q., & Zhang, C. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201311227 · Cited by 229
Wei, S. C., & Yang, J. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.09.009 · Cited by 225
“Modification of the pre-metastatic niche to alter its mechanical properties contributes significantly to this process [69,70].”
BackgroundThe evolving relationship of wound healing and tumor stroma
Foster, D. S., Jones, R. E., Ransom, R. C., Longaker, M. T., & Norton, J. A. (2018) · JCI Insight · doi:10.1172/jci.insight.99911 · Cited by 223
Cell adhesion and mechanical stimulation in the regulation of mesenchymal stem cell differentiation
Wang, Y., & Chen, C. S. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12061 · Cited by 220
Extracellular Matrix, a Hard Player in Angiogenesis
Mongiat, M., Andreuzzi, E., Tarticchio, G., & Paulitti, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111822 · Cited by 223
Nawaz, M., Shah, N., Zanetti, B. R., Maugeri, M., Silvestre, R. N., Fatima, F., Neder, L., & Valadi, H. (2018) · Cells · doi:10.3390/cells7100167 · Cited by 222
Active wetting of epithelial tissues
Pérez-González, C., Alert, R., Blanch-Mercader, C., Gómez-González, M., Kolodziej, T., Bazellieres, E., Casademunt, J., & Trepat, X. (2019) · Nature Physics · doi:10.1038/s41567-018-0279-5 · Cited by 220
Tumor hypoxia: From basic knowledge to therapeutic implications
Liao, C., Liu, X., Zhang, C., & Zhang, Q. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.12.011 · Cited by 223
The cancer stem cell niche: cross talk between cancer stem cells and their microenvironment
Ye, J., Wu, D., Wu, P., Chen, Z., & Huang, J. (2014) · Tumor Biology · doi:10.1007/s13277-013-1561-x · Cited by 216
“Mounting evidences suggest that ECM is an essential noncellular component of the adult stem cell niche [12].”
BackgroundInfluentialTargeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors
Miao, L., Liu, Q., Lin, C. M., Luo, C., Wang, Y., Liu, L., Yin, W., Hu, S., Kim, W. Y., & Huang, L. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-0866 · Cited by 215
Chemoresistance and the Self-Maintaining Tumor Microenvironment
Yeldag, G., Rice, A., & Del Río Hernández, A. (2018) · Cancers · doi:10.3390/cancers10120471 · Cited by 214
Anti-CD73 in Cancer Immunotherapy: Awakening New Opportunities
Antonioli, L., Yegutkin, G. G., Pacher, P., Blandizzi, C., & Haskó, G. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.01.003 · Cited by 213
The mechanics of fibrillar collagen extracellular matrix
Sun, B. (2021) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2021.100515 · Cited by 208
Astrocytes, the rising stars of the glioblastoma microenvironment
Brandao, M., Simon, T., Critchley, G., & Giamas, G. (2019) · Glia · doi:10.1002/glia.23520 · Cited by 208
Carcinoma‐associated fibroblasts: Non‐neoplastic tumour‐promoting mesenchymal cells
Polanska, U. M., & Orimo, A. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24347 · Cited by 208
Fracture healing in osteoporotic bone
Cheung, W. H., Miclau, T., Chow, S. K.-H., Yang, F. F., & Alt, V. (2016) · Injury · doi:10.1016/s0020-1383(16)47004-x · Cited by 208
Zhao, Q., Eichten, A., Parveen, A., Adler, C., Huang, Y., Wang, W., Ding, Y., Adler, A., Nevins, T., Ni, M., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2728 · Cited by 205
“4) that contribute to tumor progression (5, 6).”
BackgroundCCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors
Walens, A., DiMarco, A. V., Lupo, R., Kroger, B. R., Damrauer, J. S., & Alvarez, J. V. (2019) · eLife · doi:10.7554/elife.43653 · Cited by 205
Cancer-associated fibroblasts: A multifaceted driver of breast cancer progression
Luo, H., Tu, G., Liu, Z., & Liu, M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.018 · Cited by 204
“In theory, ECM reorganization appears to trigger and fuel a cascade associated with cancer progression [7]: dysregulated ECM dynamics disrupt tissue polarity, architecture and integrity and promote epithelial cell transformation, and activated CAFs aggravate ECM abnormality via expression of ECM remodeling enzymes.”
BackgroundInfluentialCancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment
Houthuijzen, J. M., & Jonkers, J. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9768-3 · Cited by 205
Recent Advances in Nanostrategies Capable of Overcoming Biological Barriers for Tumor Management
Huo, D., Jiang, X., & Hu, Y. (2020) · Advanced Materials · doi:10.1002/adma.201904337 · Cited by 205
Hu, X.-X., He, P.-P., Qi, G.-B., Gao, Y.-J., Lin, Y.-X., Yang, C., Yang, P.-P., Hao, H., Wang, L., & Wang, H. (2017) · ACS Nano · doi:10.1021/acsnano.7b00781 · Cited by 205
Cell plasticity in epithelial homeostasis and tumorigenesis
Varga, J., & Greten, F. R. (2017) · Nature Cell Biology · doi:10.1038/ncb3611 · Cited by 204
Extracellular vesicles are integral and functional components of the extracellular matrix
Rilla, K., Mustonen, A.-M., Arasu, U. T., Härkönen, K., Matilainen, J., & Nieminen, P. (2019) · Matrix Biology · doi:10.1016/j.matbio.2017.10.003 · Cited by 204
Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling
Tang, X., Hou, Y., Yang, G., Wang, X., Tang, S., Du, Y.-E., Yang, L., Yu, T., Zhang, H., Zhou, M., et al. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.78 · Cited by 200
“The microenvironment and tumor cells interact with each other.(24) The presence of CAFs, a major component of the tumor stroma, signifies tumor progression; however, the complex nature of CAF activation in vivo and the underlying cancer-promoting effects have yet to be explored.”
BackgroundLazzari, G., Couvreur, P., & Mura, S. (2017) · Polymer Chemistry · doi:10.1039/c7py00559h · Cited by 200
Cysteine cathepsins in extracellular matrix remodeling: Extracellular matrix degradation and beyond
Vizovišek, M., Fonović, M., & Turk, B. (2019) · Matrix Biology · doi:10.1016/j.matbio.2018.01.024 · Cited by 200
Interfacial geometry dictates cancer cell tumorigenicity
Lee, J., Abdeen, A. A., Wycislo, K. L., Fan, T. M., & Kilian, K. A. (2016) · Nature Materials · doi:10.1038/nmat4610 · Cited by 196
Sapudom, J., Rubner, S., Martin, S., Kurth, T., Riedel, S., Mierke, C. T., & Pompe, T. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.022 · Cited by 195
Tumor microenvironment: The culprit for ovarian cancer metastasis?
Luo, Z., Wang, Q., Lau, W. B., Lau, B., Xu, L., Zhao, L., Yang, H., Feng, M., Xuan, Y., Yang, Y., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.04.038 · Cited by 194
“However, the unique structure and biochemical diversity of the ECM makes it a significant regulator of cell behavior [78].”
BackgroundExtracellular DNA NET-Works With Dire Consequences for Health
Sorvillo, N., Cherpokova, D., Martinod, K., & Wagner, D. D. (2019) · Circulation Research · doi:10.1161/circresaha.119.314581 · Cited by 194
Directed migration of mesenchymal cells: where signaling and the cytoskeleton meet
Bear, J. E., & Haugh, J. M. (2014) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.06.005 · Cited by 191
“The directional migration cues in these situations are incompletely understood, but in the case of mammary adenocarcinoma these cells are responding to EGF cues released by tissue macrophages [80] as well as mechanical stiffness of the surrounding matrix [81,82].”
BackgroundVariation in genomic landscape of clear cell renal cell carcinoma across Europe
Scelo, G., Riazalhosseini, Y., Greger, L., Letourneau, L., Gonzàlez-Porta, M., Wozniak, M. B., Bourgey, M., Harnden, P., Egevad, L., Jackson, S. M., et al. (2014) · Nature Communications · doi:10.1038/ncomms6135 · Cited by 193
Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy
Tahmasebi Birgani, M., & Carloni, V. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020405 · Cited by 193
“It seems that such topography facilitates the tumor angiogenesis and invasion [102].”
BackgroundComplex mechanics of the heterogeneous extracellular matrix in cancer
Malandrino, A., Mak, M., Kamm, R. D., & Moeendarbary, E. (2018) · Extreme Mechanics Letters · doi:10.1016/j.eml.2018.02.003 · Cited by 192
Shen, M., Jiang, Y.-Z., Wei, Y., Ell, B., Sheng, X., Esposito, M., Kang, J., Hang, X., Zheng, H., Rowicki, M., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2018.11.016 · Cited by 191
Tumor Abnormality-Oriented Nanomedicine Design
Zhou, Q., Xiang, J., Qiu, N., Wang, Y., Piao, Y., Shao, S., Tang, J., Zhou, Z., & Shen, Y. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00062 · Cited by 188
Yuzhalin, A. E., Gordon-Weeks, A. N., Tognoli, M. L., Jones, K., Markelc, B., Konietzny, R., Fischer, R., Muth, A., O’Neill, E., Thompson, P. R., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07306-7 · Cited by 188
Bone tissue remodeling and development: Focus on matrix metalloproteinase functions
Paiva, K. B. S., & Granjeiro, J. M. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.07.034 · Cited by 189
Synthetic Mimics of the Extracellular Matrix: How Simple is Complex Enough?
Kyburz, K. A., & Anseth, K. S. (2015) · Annals of Biomedical Engineering · doi:10.1007/s10439-015-1297-4 · Cited by 189
Drug targeting to myofibroblasts: Implications for fibrosis and cancer
Yazdani, S., Bansal, R., & Prakash, J. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.010 · Cited by 189
Contribution of adipose tissue to development of cancer
Cozzo, A. J., Fuller, A. M., & Makowski, L. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c170008 · Cited by 188
“Furthermore, disruption of ECM structure or misinterpretation of ECM-derived signals due to alterations in signaling receptor profiles is associated with development of a malignant phenotype in transformed epithelial cells (43,141,230).”
Büll, C., Boltje, T. J., Wassink, M., de Graaf, A. M. A., van Delft, F. L., den Brok, M. H., & Adema, G. J. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0279 · Cited by 187
Pickup, M. W., Laklai, H., Acerbi, I., Owens, P., Gorska, A. E., Chytil, A., Aakre, M., Weaver, V. M., & Moses, H. L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0012 · Cited by 187
“The ECM acts as a foundation upon which tumors build themselves, a scaffold for blood and lymphatic vessels, and a trigger for integrin tomediate cellular changes to promote growth and migration (29).”
Self-citationKucharzewska, P., & Belting, M. (2013) · Journal of Extracellular Vesicles · doi:10.3402/jev.v2i0.20304 · Cited by 186
Collagen VI in cancer and its biological mechanisms
Chen, P., Cescon, M., & Bonaldo, P. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.04.001 · Cited by 186
Gordon-Alonso, M., Hirsch, T., Wildmann, C., & van der Bruggen, P. (2017) · Nature Communications · doi:10.1038/s41467-017-00925-6 · Cited by 186
Ji, T., Zhao, Y., Ding, Y., & Nie, G. (2013) · Advanced Materials · doi:10.1002/adma.201300299 · Cited by 183
Pivotal role for decorin in angiogenesis
Järveläinen, H., Sainio, A., & Wight, T. N. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.01.023 · Cited by 182
Dynamically tunable cell culture platforms for tissue engineering and mechanobiology
Uto, K., Tsui, J. H., DeForest, C. A., & Kim, D.-H. (2017) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2016.09.004 · Cited by 183
Brauchle, E., Kasper, J., Daum, R., Schierbaum, N., Falch, C., Kirschniak, A., Schäffer, T. E., & Schenke-Layland, K. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.016 · Cited by 182
MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits
Liu, H., Radisky, D. C., Yang, D., Xu, R., Radisky, E. S., Bissell, M. J., & Bishop, J. M. (2012) · Nature Cell Biology · doi:10.1038/ncb2491 · Cited by 181
Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance
Yu, T., Department of Breast Surgery, F. U. S. C. C., Di, G., & Department of Oncology, S. M. C. (2017) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2017.03.10 · Cited by 179
Metadata
- Authors
- Lu, P., Weaver, V. M., & Werb, Z.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Werb, Zena
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2012-02-20
- Volume
- 196
- Issue
- 4
- Pages
- 395-406
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC3283993
- OpenAlex
- W2132566055
- Semantic Scholar
- 3fca40f6a3c524e3208a0f95c34cd67f453bae03
- Cited by
- 3,024
- References
- 144
- Citations by year
- 2026: 136 · 2025: 155 · 2024: 155 · 2023: 214 · 2022: 207 · 2021: 290 · 2020: 284 · 2019: 268 · 2018: 275 · 2017: 251 · 2016: 254 · 2015: 191 · 2014: 180 · 2013: 117 · 2012: 43
- FWCI
- 15.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Cell Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA138818, P50CA058207, R01CA057621)
- National Institute of Environmental Health Sciences (U01ES019458)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R03HD060807)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- extracellular matrix, tumor microenvironment, tumor progression, metastasis, cell transformation, stromal cells, tumor angiogenesis, inflammation, ECM composition, ECM-targeted therapy
- MeSH terms
- Extracellular Matrix, Humans, Neoplasms, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.